EGFR and neoplasm: As shown in Fig. 7a, tumor cells in some patients might evolve with multiple mutations including T790M, C797S, plus the original EGFR-TKI-sensitive mutations (SM: sensitive mutation, e.g., L858R or Del19 E746_A750) (Fig. 7a).